Annalise Enterprise Radiology AI Solutions
by Annalise.ai
AI Solution for Chest X-ray and CT Brain for Triage and report generation for use by all clinicians
Annalise.ai develops comprehensive AI products in Radiology (Chest X-ray, Non Contrast CT Brain) that seamlessly integrate with the physician’s workflow and the organization's IT systems.
Our products can help (a) triage studies, (b) assist a clinician while reporting a study and (c) automatically draft a preliminary report for sign off by a clinician.
This has had an impact on (i) quality, by reducing missed diagnostics, (ii) efficiency, by reducing turn around time and (iii) capacity, by allowing qualified clinicians to interpret studies with the help of AI.
Comprehensive Chest X-ray: Annalise AI looks for 124 findings + Tuberculosis on Chest X-ray. These findings can be used in various settings including:
- Screening for: (a) TB (b) Pulmonary diseases (COPD, Silicosis) (c) Lung Cancer Screening (d) Heart Failure
- Inpatient setting: (a) Lines and Tubes, (b) Sepsis
- Emergency: (a) Fractures, (b) Pneumothorax etc.
Comprehensive Non-Contrast CT Brain: Annalise AI looks for 130 findings on CT Brain. These findings can be used in various settings including.
- Emergency: ICH, Stroke, Skull Fracture
- Screening for: Atrophy, Brain Tumour etc.
- Inpatient setting: continued monitoring for patients with Surgery etc.
Annalise.ai can be used in several settings:
- Triage cases for immediate review
- Assist radiologists by (a) making them more efficient, and more (b) accurate.
- Write a preliminary report for review and sign off by a radiologist.
Workflow integration:
- Annalise.ai results can be integrated with existing PACS, RIS and EMR systems or viewed on Annalsie.ai Web based viewer.
Clinical validation:
- Our CXR and CTB products have been validated extensively and we have more than 40 publications in various global journals.
- Our products perform very well in all settings including in India
Annalise Enterprise is classified as a Software as a Medical Device and hence would requires regulatory approvals. Annalise is approved for sale in 40+ countries but the product may vary according to the regulations applicable in each market. Please contact us for further information.
For more information visit us at: www.annalise.ai